This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Cybin Irl Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Alex Belser: Innovator in Therapeutic Phenethylamine Compositions
Introduction
Alex Belser is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of therapeutic compounds, particularly focusing on phenethylamine compositions. His innovative work aims to address various diseases associated with serotonin receptors.
Latest Patents
Alex Belser holds a patent for "Therapeutic phenethylamine compositions and methods of use." This patent discloses deuterated 2C—X phenethylamine compounds and their applications in treating diseases linked to the serotonin 5-HT receptor. The patent also includes pharmaceutical compositions, such as tablet formulations and kits containing these compounds. Furthermore, it outlines methods for delivering the compounds via inhalation mist and treating central nervous system (CNS) disorders or psychological disorders.
Career Highlights
Belser is currently associated with Cybin Irl Limited, where he continues to develop and refine his innovative ideas. His work is pivotal in advancing therapeutic options for patients suffering from various disorders.
Collaborations
Some of his notable coworkers include Clinton E Canal and Brett J Greene, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Alex Belser's contributions to the field of therapeutic phenethylamine compositions highlight his commitment to innovation and improving healthcare solutions. His work continues to pave the way for advancements in treating psychological and CNS disorders.